172 related articles for article (PubMed ID: 3336017)
1. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
Bock MG; DiPardo RM; Evans BE; Rittle KE; Veber DF; Freidinger RM; Chang RS; Lotti VJ
J Med Chem; 1988 Jan; 31(1):176-81. PubMed ID: 3336017
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.
Bock MG; DiPardo RM; Evans BE; Rittle KE; Freidinger RM; Chang RS; Lotti VJ
J Med Chem; 1988 Jan; 31(1):264-8. PubMed ID: 3336026
[No Abstract] [Full Text] [Related]
3. Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.
Bock MG; DiPardo RM; Evans BE; Rittle KE; Whitter WL; Veber DF; Freidinger RM; Chang RS; Chen TB; Lotti VJ
J Med Chem; 1990 Jan; 33(1):450-5. PubMed ID: 2153212
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
Satoh M; Okamoto Y; Koshio H; Ohta M; Nishida A; Akuzawa S; Miyata K; Mase T; Semple G
Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
6. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
Lotti VJ; Chang RS
Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
Chang RS; Lotti VJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4923-6. PubMed ID: 3014520
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
Cappelli A; Anzini M; Vomero S; Menziani MC; De Benedetti PG; Sbacchi M; Clarke GD; Mennuni L
J Med Chem; 1996 Feb; 39(4):860-72. PubMed ID: 8632410
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
[TBL] [Abstract][Full Text] [Related]
11. Development of 1,4-benzodiazepine cholecystokinin type B antagonists.
Bock MG; DiPardo RM; Evans BE; Rittle KE; Whitter WL; Garsky VM; Gilbert KF; Leighton JL; Carson KL; Mellin EC
J Med Chem; 1993 Dec; 36(26):4276-92. PubMed ID: 8277510
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.
Bock MG; DiPardo RM; Rittle KE; Evans BE; Freidinger RM; Veber DF; Chang RS; Chen TB; Keegan ME; Lotti VJ
J Med Chem; 1986 Oct; 29(10):1941-5. PubMed ID: 3761313
[TBL] [Abstract][Full Text] [Related]
13. Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419.
Tabuchi S; Ito H; Sogabe H; Kuno M; Kinoshita T; Katumi I; Yamamoto N; Mitsui H; Satoh Y
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):1-15. PubMed ID: 10705468
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-stimulated pepsinogen secretion and cholecystokinin receptors on gastric chief cells in guinea pigs.
Noguchi M; Adachi H; Sato S; Honda T; Ohnishi S; Aoki E; Torizuka K
Endocrinol Jpn; 1987 Oct; 34(5):727-36. PubMed ID: 3436302
[TBL] [Abstract][Full Text] [Related]
15. Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.
Lin CW; Bianchi BR; Miller TR; Witte DG; Wolfram CA
Am J Physiol; 1992 Jun; 262(6 Pt 1):G1113-20. PubMed ID: 1616041
[TBL] [Abstract][Full Text] [Related]
16. Tifluadom, a kappa-opiate agonist, acts as a peripheral cholecystokinin receptor antagonist.
Chang RS; Lotti VJ; Chen TB; Keegan ME
Neurosci Lett; 1986 Dec; 72(2):211-4. PubMed ID: 3027627
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cholecystokinin receptors on guinea pig gastric chief cell membranes.
Matozaki T; Sakamoto C; Nagao M; Nishisaki H; Konda Y; Nakano O; Matsuda K; Wada K; Suzuki T; Kasuga M
Biochem Biophys Res Commun; 1991 Feb; 174(3):1055-63. PubMed ID: 1996975
[TBL] [Abstract][Full Text] [Related]
18. Structural features of various proglumide-related cholecystokinin receptor antagonists.
Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
[TBL] [Abstract][Full Text] [Related]
19. Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.
Evans BE; Rittle KE; Bock MG; DiPardo RM; Freidinger RM; Whitter WL; Gould NP; Lundell GF; Homnick CF; Veber DF
J Med Chem; 1987 Jul; 30(7):1229-39. PubMed ID: 2885419
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
